Ibufen Mini Junior

Ibuprofen, the active ingredient in Ibufen Mini Junior, is a nonsteroidal anti‑inflammatory drug (NSAID) presented as an oral formulation for oral use. It is used to relieve pain, reduce fever, and lessen inflammation in children and adolescents.

GNH USA supplies Ibufen Mini Junior as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ibuprofen acts on the cyclooxygenase pathway to manage common inflammatory conditions. - Pain: provides temporary relief of mild to moderate pain such as headache, toothache, or musculoskeletal discomfort. - Fever: lowers elevated body temperature associated with viral or bacterial infections. - Inflammation: reduces swelling and redness in conditions like minor sprains or soft‑tissue injuries.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia, or mild abdominal pain. - Headache: transient mild headache. - Dizziness: occasional light‑headedness. - Rash: mild skin redness or itching. - Elevated liver enzymes: asymptomatic laboratory finding.

Serious or Rare Side Effects: - Gastrointestinal bleeding or ulceration. - Severe allergic reactions: angioedema, anaphylaxis. - Renal impairment: reduced kidney function or acute failure. - Hepatotoxicity: significant liver injury. - Cardiovascular events: increased risk of thrombotic episodes.

Before using Ibufen Mini Junior, consider the following safety measures. - Age limitation: intended for pediatric use as directed by a healthcare professional. - Existing conditions: avoid if the child has a history of peptic ulcer disease, severe asthma, or renal impairment. - Concomitant NSAIDs: do not combine with other non‑steroidal anti‑inflammatory drugs. - Allergies: discontinue if signs of hypersensitivity appear. - Store at ambient temperature: keep below 25 °C, retain in original packaging, and protect from moisture.

Ibuprofen can affect the activity of several other medicines.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - High‑dose aspirin: heightened gastrointestinal toxicity. - Certain antihypertensives (e.g., ACE inhibitors, diuretics): may reduce blood‑pressure control.

Moderate Interactions (Monitor Closely): - Selective serotonin reuptake inhibitors (SSRIs): potential for bleeding. - Lithium: possible rise in lithium serum levels. - Methotrexate: reduced renal clearance may increase toxicity.